AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 145 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $189,608 | +121.7% | 17,300 | -12.6% | 0.01% | +100.0% |
| Q4 2022 | $85,536 | +21337.6% | 19,800 | -62.7% | 0.01% | -80.6% |
| Q3 2022 | $399 | -45.2% | 53,100 | -26.7% | 0.03% | -46.6% |
| Q2 2022 | $728 | -25.9% | 72,400 | -8.8% | 0.06% | -12.1% |
| Q1 2022 | $983 | -58.1% | 79,400 | -22.6% | 0.07% | -63.7% |
| Q4 2021 | $2,346 | +38.6% | 102,600 | +34.1% | 0.18% | +10.3% |
| Q3 2021 | $1,693 | +46.3% | 76,500 | -14.3% | 0.16% | +20.4% |
| Q2 2021 | $1,157 | -0.3% | 89,300 | 0.0% | 0.14% | -23.9% |
| Q1 2021 | $1,160 | -8.6% | 89,300 | -2.7% | 0.18% | -28.9% |
| Q4 2020 | $1,269 | +18.4% | 91,750 | +26.1% | 0.25% | -1.2% |
| Q3 2020 | $1,072 | -99.9% | 72,750 | +17.5% | 0.26% | 0.0% |
| Q2 2020 | $1,006,000 | +26.2% | 61,900 | +12.7% | 0.26% | +24.3% |
| Q1 2020 | $797,000 | – | 54,902 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |